-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EsAfkpgogaVvAfkPBtZwRMnMZAs9NYR/Tz3LDwYK9JIzPgS21kqnDbWOR20DPZ5Y vtxb3KZbC14FA74w+6qgpg== 0001035973-98-000006.txt : 19980330 0001035973-98-000006.hdr.sgml : 19980330 ACCESSION NUMBER: 0001035973-98-000006 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980327 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMASYSTEMS HOLDINGS CORP CENTRAL INDEX KEY: 0001027763 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 841189040 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: SEC FILE NUMBER: 000-21851 FILM NUMBER: 98576098 BUSINESS ADDRESS: STREET 1: 7350 NW 7TH ST STREET 2: STE 104 CITY: MIAMI STATE: FL ZIP: 33126 BUSINESS PHONE: 3052679500 MAIL ADDRESS: STREET 1: 7350 NW 7TH ST STREET 2: STE 104 CITY: MIAMI STATE: FL ZIP: 33126 FORMER COMPANY: FORMER CONFORMED NAME: EURO TEL INC DATE OF NAME CHANGE: 19961129 15-12G 1 NOTICE OF TERMINATION OF REGISTRATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number 0-2185 PharmaSystems Holdings Corp. (Exact name of registrant as specified in its charter) 7350 NW 7th Street, Suite 104 Miami, Florida 33126 (305) 267-9500 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Stock, no par value (Title of each class of securities covered by this Form) None (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1)(i) [x] Rule 12h-3(b)(1)(ii) [x] Rule 12g-4(a)(1)(ii)[x] Rule 12h-3(b)(2)(i) [ ] Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ] Rule 12g-4(a)(2)(ii)[ ] Rule 15d-6 [x] Rule 12h-3(b)(1)(i) [x] Approximate number of holders of record as of the certification or notice date: 113 (as of March 26, 1998) Pursuant to the requirements of the Securities Exchange Act of 1934 PharmaSystems Holdings Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. /s Aurelio Alonso Dated: March 27, 1998 By: ------------------------------------- Aurelio Alonso Executive Vice President and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----